PRP Hair Restoration

PRP for Hair Loss in Abu Dhabi : Evidence, Mechanism & Treatment Planning

Platelet-rich plasma (PRP) is an autologous treatment made from a patient’s own blood and concentrated platelets. In hair restoration research, platelet-derived growth factors and cytokines are proposed to support follicular cell survival, angiogenesis and anagen-phase activity. The supplied chapter reports evidence of improved hair density in androgenetic alopecia and more hair regrowth than placebo in alopecia areata, but also emphasizes that PRP preparation and treatment protocols are not yet standardized.

What Is PRP Hair Treatment?

PRP is a concentrated platelet-containing fraction prepared from a patient’s own blood. The source chapter describes PRP as an off-label option studied for hair loss. After preparation, PRP may be activated and introduced into areas of hair loss with the aim of supporting hair growth, cell survival, proliferation and angiogenesis.

PRP should not be presented as a universal cure for all alopecia. Hair loss can be scarring or non-scarring, and the underlying diagnosis changes the treatment strategy. Androgenetic alopecia (AGA) and alopecia areata (AA) have the most relevant evidence discussed in the source chapter, while the evidence for cicatricial or scarring alopecia remains limited.

Why Hair Loss Is More Than a Single-Pathway Problem

The chapter highlights chronic follicular micro-inflammation as one potential contributor to hair loss, including pattern hair loss. Micro-inflammation may involve immune-cell activity around the follicular bulge and may contribute to premature entry into catagen, altered stem-cell renewal and disrupted hair cycling.

In AGA, androgen signaling—particularly dihydrotestosterone (DHT)—can interfere with pathways that support transition from telogen to anagen. PRP is discussed as a multifactorial treatment because its growth-factor signals may interact with several pathways rather than one isolated target.

How PRP May Support the Hair Cycle

The source describes PRP-associated activation of Wnt/β-catenin signaling as one proposed route for supporting entry into the anagen phase. Growth-factor signaling may also act through ERK, Akt and JNK pathways, which are associated with cell proliferation, survival and reduced apoptosis. In parallel, angiogenic factors may support perifollicular vascularization and influence follicle size.

Key Growth Factors in PRP Hair Restoration

What Does the Evidence Say for Androgenetic Alopecia?

The chapter cites a meta-analysis in which three monthly PRP sessions produced a greater mean change in hair density than placebo. The pooled mean difference was 25.61 hairs/cm² (95% CI 4.45–46.77; p=0.02; pooled n=58). Other AGA studies cited in the chapter reported significant improvements in hair diameter measured three to six months after treatment.

The direction of evidence in the supplied chapter is favorable for hair density and hair diameter in AGA, but the studies use different PRP systems, platelet concentrations, activation methods and delivery protocols. The chapter therefore does not support claiming one universally superior PRP protocol.

PRP and Alopecia Areata

The source describes two randomized controlled trials in which monthly PRP for three months produced significantly more hair regrowth than placebo, with earlier pigmented hair regrowth in PRP-treated patients. The chapter’s conclusion, however, notes that other disease-specific therapies may be preferable and that PRP evidence in AA should be interpreted as preliminary rather than definitive.

PRP Around Hair Transplantation

The supplied chapter also reviews PRP as an adjunct to hair-restoration procedures. Studies cited in the chapter reported more actively growing follicles after intraoperative PRP and greater follicular-unit yield with PRP-soaked grafts compared with placebo controls. The authors still recommend caution around timing and note that excessive intraoperative volume may contribute to shock loss; they favor pre- and post-treatment injections rather than excess intraoperative injection.

Before & After PRP Hair Treatment

Is There a Standard PRP Protocol for Hair Loss?

No. The chapter explicitly states that a standardized PRP protocol for alopecia has not yet been established. This is a critical point for patient communication and for medically responsible website copy.

Research summarized in the chapter suggests that monthly sessions may perform better than treatment every three months for hair-count outcomes. It also reports evidence that three monthly sessions can outperform placebo and that two to five sessions have been associated with improvements in hair diameter. A minimum initial series followed by maintenance has been proposed because gains in hair density may be transient.

How PRP Is Delivered to the Scalp

The source notes that interfollicular injections and microneedling have both been used to deliver PRP in hair-loss studies. It also describes an author-preferred subdermal method intended to distribute PRP around the base of the hair follicle and into connective tissue. Because this preference is author opinion rather than a standardized consensus, it should not be presented as the only correct technique.

Why PRP Composition Matters

The chapter repeatedly emphasizes that treatment performance is strongly influenced by what the PRP preparation contains. It argues that large amounts of red and white blood cells may reduce effectiveness and states that effective PRP solutions should be low in red and white blood cells while containing elevated platelets, stimulating growth factors and cytokines.

The clinical value of activation methods is less certain. Different activators can alter growth-factor release and pH, but the chapter describes conflicting data and concludes that further research is needed. Both relatively low and high platelet concentrations have been associated with increased hair density in published studies, so a single ideal concentration is not established by this source.

Clinical Assessment Before PRP

• Confirm the type of hair loss rather than treating “hair shedding” as a single diagnosis.
• Differentiate patterned non-scarring alopecia from alopecia areata and from suspected scarring alopecia.
• Review previous and current hair-loss therapies so PRP can be positioned as monotherapy or an adjunct where evidence supports that role.
• Set expectations around an initial treatment series, delayed assessment of density/diameter and the possible need for maintenance.
• Explain that preparation systems and protocols vary and that treatment response is not identical between patients.

PRP Alone vs Combination Treatment

Realistic Expectations

A patient-facing page should focus on measurable concepts—hair density, hair diameter, hair shedding and photographic change—rather than guaranteed “regrowth.” The source reports positive signals for density and diameter, but also highlights protocol variability and the need for larger controlled studies, especially outside AGA.